Alexion Pharmaceuticals’s founder retires as Chairman of the Board, current CEO to succeed him

Alexion Pharmaceuticals’s founder retires as Chairman of the Board, current CEO to succeed him

March 3, 2017 Off By Dino Mustafić

Leonard Bell, founder of Alexion Pharmaceuticals will not stand for reelection as a Board member and will retire as Chairman of the Board and as a Director at the end of his term, effective as of the Annual Meeting of Shareholders scheduled for May 10, 2017.

The company has informed that Bell’s place as Chairman will take David Brennan, Alexion’s Interim Chief Executive Officer and Board member.

Bell said, “I am incredibly proud of all that we have achieved over the past 25 years since Alexion was founded, and I have great confidence in the future of the Company. Since my retirement as CEO in 2015, it has been highly gratifying to continue to work closely with the Board and management as Chairman. I am very much looking forward to spending increasing time with my family, and also exploring new and different opportunities. I am extremely grateful to and would like to thank all the employees of Alexion and, most importantly, encourage them to continue their important mission of discovering and developing new breakthrough therapies to transform the lives of patients who suffer from rare and devastating disorders.”